CD19 and systemic lupus erythematosus: Add-on belimumab was shown to exert an overall protective effect, which however did not reach significance in the models of CD19+CD20+CD27+ memory B cells, CD19+CD20-CD138+ long-lived plasma cells and CD19+CD27brightCD38bright SLE-associated plasma cells (Figure 5B; Supplementary Table S4).